Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,364Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Bosulif

PharmaCompass

01

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2019 Revenue in Millions : 365

2018 Revenue in Millions : 296

Growth (%) : 23

blank

02

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 450

2019 Revenue in Millions : 365

Growth (%) : 23

blank

03

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 540

2020 Revenue in Millions : 450

Growth (%) : 20

blank

04

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 575

2021 Revenue in Millions : 540

Growth (%) : 6

blank

05

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 645

2022 Revenue in Millions : 575

Growth (%) : 12

blank

06

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2017 Revenue in Millions : 233

2016 Revenue in Millions : 167

Growth (%) : 40

blank

07

Brand Name : Bosulif

Bosutinib

arrow
BIO Asia-Taiwan
Not Confirmed

Brand Name : Bosulif

arrow
BIO Asia-Taiwan
Not Confirmed

Bosutinib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 375

2017 Revenue in Millions : 233

Growth (%) : 61%

blank